These 3 studies formed a meta-analysis that was recently named by Dr Antony Fauci as one of the top five clinical highlights in the world. What they show is death rates halved and ICU stays substantially reduced. In the Financial Times, Dr Fauci urgently called for more and much larger studies into to these readily available drugs.
Dr Freeman has vast experience with these medicines, having cured over 3000 hepatitis C patients. GHNZ is responding to the call for more trials. A network of trials is now underway in 7 countries. Results will be available from early November 2020. The bigger the trials are, the more sure the world can be we have an effective treatment.
Global Health New Zealand believes that now, August 2020, there is a serious imbalance between vaccine research and small molecule treatment research funding. We are working to help correct that and are currently calling on the New Zealand Government and collecting donations to increase the size of the trial starting shortly in Brazil.
Please contact us if you can help us solve the most urgent problem in global health or want to know more. Charitable donation receipts can be given for NZ, USA, Brazil and Australia.
2019 found me in a conference hall in Boston. I was tired, I had come to the
end of three days on an NGO stand at the biggest liver conference in the world.
Almost time to pack up. I was there promoting our new global symbol for the
highly stigmatised virus, the Hep C butterfly.
As we had
found everywhere in the world, I’d had overwhelming support, thousands of ‘feel
good’ butterfly items taken and endorsements of it as the global symbol signed.
It was on the lapels of most of the
eminent clinicians there. It really happened, the #hepcbutterfly has become
like the daffodil is for cancer. People walk towards it and the stigma is gone.
They talk, ask questions and it leads to treatment.
Many smiles and selfies later. I had travelled from New Zealand and done the conference alone, I was almost talked out. One more person approached, smiling in advance, as so many did at the stall. I had seen thousands of faces but this face…it was one of those frozen moments, searching my mind because I knew this was significant. I’m glad to say it came quickly, and the conference lanyard came in handy to confirm.
I realised it was the man to whom I owed my life. The legendary virologist
who invented the world’s first, and only cure for a virus. I thought about all
the people I knew… actually the millions of us who would not be alive now but
for his ground breaking work. Breakthroughs not ‘just’ for Hep C; but Hep B and
HIV as well. One of the scientists of the century.
I’m not easily overwhelmed but it was a big moment. We talked, he was
happy to endorse our symbol for the virus he cured. He wanted to know how I
felt, what the difference was for me, he is a researcher and does not speak to
many people like me, a survivor thanks to sofosbuvir.
I was able to tell him- I was at death’s door. My liver was failing and I
had Hep C all my adult life. Your miracle drug arrived just in time, I am twice
the person I was before and have since completed a law degree. I was able to
tell him of the thousands of survivors I am connected to on social media and
thank him for us all.
In these new extraordinary times, conferences like this are now
impossible. We swapped contacts, and have kept in touch a little. The man
behind my miracle continues to work on viral solutions and I keep using my new
life to give others the news about the cure. This moment captured is one I
won’t forget. There are even more challenges to be met in global health now,
and thanks to Professor Schinazi, I have work to do.
David Gold and Victor Zonana created Global Health Strategies in 2002. In founding GHS, they drew upon their individual experiences in HIV activism, media, industry and government. The result was a company that leveraged communications and advocacy to help organizations bring comprehensive change to international health and development.
In the years since, GHS has grown from a New York-based company serving clients based in the United States and Europe to a global network with a focus on emerging markets. This issue expertise has expanded beyond its initial grounding in infectious diseases to include a wide variety of health and development challenges, ranging from research and development to climate change to family planning services. We now have offices in the US, Brazil, India, China, Africa and Europe. GHS has expanded its client base to include philanthropies, industry, multinational organizations, NGOs and governments. The result is a collection of fully integrated offices working to address the most pressing issues of the 21st century.
At the heart of GHS’s work is the vision of a world where everyone, no matter where they live, has the chance to live a healthy life. We are helping to achieve this goal by working with clients to promote research and development for urgently needed medicines, advocate for services on behalf of at-risk populations, and strengthen the most vulnerable health systems so that they can stand resilient in the face of modern threats. The world has made remarkable progress on all of these fronts in recent decades, giving us hope, resolve and ambition to do even better in the future.
Written by Hazel Heal, a human rights lawyer, Edmund Hillary Fellow, and lead advocate for Hep C Action Aotearoa, Dunedin, New Zealand
I should not be alive to write this. It took a medical miracle, the world’s first ever cure for a virus, and some close timing. It also took me pushing back on the pervasive stigma.
I am a human rights lawyer from New Zealand, recently admitted to the bar. It took me until my fifties to achieve this because I lived my whole adult life under the fog of hepatitis C (hep C).
Hep C and I share a storyline: I was diagnosed when the test was developed in 1992 and subsequently have had biopsies, undergone two rounds of interferon/ribavirin, and progressed all the way to decompensating cirrhosis. In 2015, it seemed like my time had run out. I did however learn about the miracle cure at $84,000 per treatment, which to me was out of reach. I managed to obtain some through personal importation of generics and thankfully made a full recovery. 1
Following this journey, I have been using my new energy, my second chance, to increase access to treatment and raise awareness.
Hep C Stigma Kills
In New Zealand, like many places, approximately 40% of liver transplantees have no idea they are hep C virus (HCV) positive until they reach the severity of sickness that requires a transplant.2 They must have been chronically ill for years yet not been diagnosed with the virus. The reason for this is the endemic stigma. It is dangerous, illogical, and costs health systems money. Hep C affects at least 1% of the population worldwide, meaning that millions of people need to hear: “Hey! This could be you.”
That message is not getting through globally because we keep doing the same thing and expecting a different outcome. We are looking for the undiagnosed through targeted messaging, that singles people out, shining a torch on their past or present lifestyle, potentially ignoring those who are in need of a diagnosis.
It is not about How, it is about Now
Around 20% of those who are HCV positive did not become infected through intravenous drug use.3 Many who did get it from equipment sharing did this many years ago, maybe only once, and do not identify with the risks. People who use drugs may also wish not to be stereotyped. An important fact to remember is that every single one of us was infected accidently.
Everyone takes risks, whether they are obvious or not: skiers, motorcyclists, even dancers cost health systems money and resources. Hep C campaigns often focus on the risks, which reads like legislation. There is the suggestion of fault. If made uncomfortable, people tend to look away because they can. By focussing on the benefits and the good news, the message can be made attractive and therefore reach more people who are undiagnosed.
I know how important it is to have patient advocates because I represent thousands that cannot speak publicly. I have been the administrator of, or senior contributor to, online groups including >10,000 global patients with hep C. I started the group Hep C Action, have spoken at national and international conferences, and am the patient representative on my regional and national hep C government committees. Through this I hear the stories of casual, careless, or deliberate stigmatising by family, workmates, and health professionals. I have even personally experienced it.
We have a Solution for Everyone, Everywhere, to Erase Stigma
There is a marketing norm of “who is your target audience.” It is nearly always right, but this virus is different, and that approach is not working. Society is the target. The stigma must be turned on its head if people are going to be encouraged to get tested. Everyone needs to be told: “If you test negative, that is good news; but testing positive is also good news. You will feel better when treated.”
In 2017, my Hep C Action colleague Dr James Freeman conceived of and commissioned the #hepcbutterfly to symbolise HCV.4 The colourful figure represents metamorphosis and the butterfly effect of people being cured. It creates an umbrella to the ‘get tested’ message that shelters everyone from the glare.
Hep C did not have an international identity, despite it being twice as prevalent as HIV, for example.5 The #hepcbutterfly is our red ribbon, our daffodil. This symbol is a pivotal world health moment; it dismantles stigma. People take two steps forward, instead of backward. It catches the eye in an overcrowded market. It routinely triggers conversations and, ultimately, treatment.
Thousands of clinicians, patients, researchers, and marketing experts have resoundingly endorsed it. We have given away thousands of lapel pins and constructed billboards and giant posters. In New Zealand, following these campaigns we have recently seen testing numbers rise. We should test everyone.6
I recently became aware of a woman in her early 60’s; she has pierced ears and a tattoo out of sight, yet her doctor assured her she was not the ‘type’ to need a test, even with those risks and accompanying symptoms. I am simply asking clinicians to suspend assumptions and test your patients regardless of risk factors. Test anyway. That is the only way we will find the missing.
Doctors stigmatise people by making assumptions and testing only when they think there is a good chance of finding something, someone who “potentially has hep C” you may say. That keeps missing the people who are hardest to find. Stigma in medicine is very high, whether it be inadvertent or not; unfortunately, I know from experience that clinicians do not think it means them, so they do not change themselves, or are sometimes offended by the suggestion that they might be acting under preconceptions. The woman whose story I told, her doctor thinks that she is being nice and supportive by telling her she does not need to be tested for hep C, but ultimately despite her kindness, she is not actually helping. Stigma is rife across society, so telling doctors to “test everyone” is the only way to convey the need to test anyone who presents with hep C symptoms, despite their lifestyle or whether the doctor thinks that the patient is potentially infected. Realistically, everyone could potentially be infected.
Call to Action
Here is what you can do. Use the symbol and melt the stigma. Add it to your national or local campaign or to wherever you are trying to tell people about hep C. Use our Hep C Action posters; adapt them, translate them, add your logo. Send us the file to continue the butterfly effect. This image and materials are free. One in a hundred pairs of eyes that is attracted to the positive message is someone like me, who needs to be treated. You can prompt them to act.